ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 428

Impact of Smoking Cessstion Advise in Patients with  Rheumatoid Arthritis to Help Quit  Smoking

Shama Khan1, Ahmad Butt1, Emmett Brennan2, Ausaf Mohammad1 and Killian O Rourke3, 1Rheumatology, Midlands Regional Hospital, Tullamore, Ireland, 2Tullamore, Midlands Regional Hospital, Tullamore, Ireland, 3Rheumatology, Midlands Regional Hospital, Tullamore, Co Offaly, Ireland

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster I: Treatment Patterns and Response

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Smoking is associated with an increased risk of comorbidities in rheumatoid arthritis (RA) and may reduce the efficacy of anti-rheumatic therapies. Smoking cessation is therefore critically important in RA management and may lead to a reduced comorbid burden (1,2). The aim of this pilot study was to investigate whether smoking cessation rates are increased following a smoking cessation advice for people with RA.

Methods:

We conducted a prospective study of one hundred and eighty RA patients fulfilling the 1987 American College of Rheumatology classification criteria, from October 2016 to March 2017, attending our rheumatology services. Ethics approval was obtained. Information on demographics and cigarette smoking status was collected through patients’ interviews and medical notes review. Current smokers were given advice on quitting smoking through face-to-face advice, handout, and nicotine replacement. Subjects were re-interviewed at 6-months to ascertain smoking status. The primary outcome was smoking cessation at 6 months.

Results:

180 current smokers with RA were included: mean age 56± 11.9 years and 76% were females. Overall, 64% of subjects stopped smoking at 6 months, and remainder RA smokers were thinking about quitting. More female subjects quit smoking as compared to males (74% vs. 26%). Those who quit smoking were younger (49 years vs. 57 years), had higher BMI (28.7 ± 3.6 vs. 26.7 ± 3.6), and had aggressive disease, DAS28-CRP (4.9 ± 0.9 vs. 2.9 ± 0.9) (P < .05). Subjects who stopped smoking stated “healthy life style” as motivation to quit.

Conclusion:

In our study significant proportion of RA patients stopped smoking when given advice on quitting. Smoking cessation advice was very beneficial in motivating them to quit smoking. There should be a structured plan in place to educate RA patients on smoking cessation, both in verbal and written form.


Disclosure: S. Khan, None; A. Butt, None; E. Brennan, None; A. Mohammad, None; K. O Rourke, None.

To cite this abstract in AMA style:

Khan S, Butt A, Brennan E, Mohammad A, O Rourke K. Impact of Smoking Cessstion Advise in Patients with  Rheumatoid Arthritis to Help Quit  Smoking [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/impact-of-smoking-cessstion-advise-in-patients-with-rheumatoid-arthritis-to-help-quit-smoking/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-smoking-cessstion-advise-in-patients-with-rheumatoid-arthritis-to-help-quit-smoking/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology